{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:48:50Z","timestamp":1792597730406,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.06.031","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T22:17:02Z","timestamp":1562019422000},"page":"A83-A92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"special_numbering":"S1","title":["Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-5380","authenticated-orcid":false,"given":"Bhabatosh","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7488-8474","authenticated-orcid":false,"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandavarayan","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.031_b0005","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMoa054493","article-title":"Single-dose azithromycin for the treatment of cholera in adults","volume":"354","author":"Saha","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.06.031_b0010","unstructured":"Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet. 2017; pii: S0140-6736(17)30559-7."},{"key":"10.1016\/j.vaccine.2019.06.031_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1126\/science.1159483","article-title":"Antibiotics and antibiotic resistance genes in natural environments","volume":"321","author":"Martinez","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.06.031_b0020","doi-asserted-by":"crossref","first-page":"j3535","DOI":"10.1136\/bmj.j3535","article-title":"Fostering research into antimicrobial resistance in India","volume":"358","author":"Das","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.06.031_b0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/genetics\/139.4.1465","article-title":"Vicious circles: looking on resistance plasmids","volume":"139","author":"Davies","year":"1995","journal-title":"Genetics"},{"key":"10.1016\/j.vaccine.2019.06.031_b0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.031_b0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00248-018-1228-7","article-title":"Molecular insights into antimicrobial resistance traits of commensal human gut microbiota","volume":"77","author":"Bag","year":"2019","journal-title":"Microb Ecol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fmicb.2016.00173","article-title":"Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer","volume":"7","author":"von Wintersdorff","year":"2016","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.031_b0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/JB.00674-15","article-title":"Effect of LexA on chromosomal integration of CTXvarphi in vibrio cholerae","volume":"198","author":"Pant","year":"2016","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0006-291X(60)90081-4","article-title":"Resistance transfer agents in Shigella","volume":"3","author":"Nakaya","year":"1960","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2019.06.031_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/br.27.1.87-115.1963","article-title":"Infective heredity of multiple drug resistance in bacteria","volume":"27","author":"Watanabe","year":"1963","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.vaccine.2019.06.031_b0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4269\/ajtmh.1946.s1-26.631","article-title":"Asiatic cholera; clinical study and experimental therapy with streptomycin","volume":"26","author":"Reimann","year":"1946","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.06.031_b0065","first-page":"763","article-title":"Oral streptomycin in the treatment of cholera","volume":"41","author":"Uylangco","year":"1965","journal-title":"J Philipp Med Assoc"},{"key":"10.1016\/j.vaccine.2019.06.031_b0070","first-page":"398","article-title":"Chloromycetin in the treatment of cholera","volume":"85","author":"Chaudhuri","year":"1950","journal-title":"Ind Med Gaz"},{"key":"10.1016\/j.vaccine.2019.06.031_b0075","first-page":"331","article-title":"Further observations on intravenous chloramphenicol in cholera","volume":"23","author":"Chakravarti","year":"1954","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.vaccine.2019.06.031_b0080","unstructured":"Carpenter CC, Sack RB, Mondal A, Mitra PP. Tetracycline therapy in cholera. J Indian Med Assoc 1964;43:309\u201312."},{"key":"10.1016\/j.vaccine.2019.06.031_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/bmj.3.5613.277","article-title":"Controlled comparison of tetracycline and furazolidone in cholera","volume":"3","author":"Pierce","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2019.06.031_b0090","first-page":"373","article-title":"Furazolidone in paediatric cholera","volume":"43","author":"Karchmer","year":"1970","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.06.031_b0095","doi-asserted-by":"crossref","unstructured":"Cash RA, Northrup RS, Mizanur Rahman AS. Trimethoprim and sulfamethoxazole in clinical cholera: comparison with tetracycline. J Infect Dis 1973;128:Suppl:749\u201353p.","DOI":"10.1093\/infdis\/128.Supplement_3.S749"},{"key":"10.1016\/j.vaccine.2019.06.031_b0100","first-page":"36","article-title":"Comparative effectiveness of co-trimoxazole and tetracycline in the treatment of cholera","volume":"30","author":"Grados","year":"1996","journal-title":"Bull Pan Am Health Organ"},{"key":"10.1016\/j.vaccine.2019.06.031_b0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.4.5730.281","article-title":"Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor","volume":"4","author":"Gharagozloo","year":"1970","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.031_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000221980","article-title":"Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol","volume":"23","author":"Pastore","year":"1977","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.031_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0035-9203(78)90297-3","article-title":"Effect of trimethoprim-sulphamethoxazole on vibrio clearance in cholera (El Tor): a comparative study","volume":"72","author":"Dutta","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.06.031_b0120","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","article-title":"The crisis in antibiotic resistance","volume":"257","author":"Neu","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.06.031_b0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-6968.2007.00757.x","article-title":"Evolution and ecology of antibiotic resistance genes","volume":"271","author":"Aminov","year":"2007","journal-title":"FEMS Microbiol Lett"},{"issue":"13","key":"10.1016\/j.vaccine.2019.06.031_b0130","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1073\/pnas.1900141116","article-title":"Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae","volume":"116","author":"Verma","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.06.031_b0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrmicro2382","article-title":"Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow","volume":"8","author":"Wozniak","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"8112","key":"10.1016\/j.vaccine.2019.06.031_b0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(79)92889-7","article-title":"Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania","volume":"1","author":"Mhalu","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2012.06.010","article-title":"Antibiotic resistance of Vibrio cholerae O1 El Tor strains from the seventh pandemic in China, 1961\u20132010","volume":"40","author":"Wang","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2019.06.031_b0150","first-page":"747","article-title":"Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania","volume":"58","author":"Towner","year":"1980","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.06.031_b0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(95)90344-5","article-title":"Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma","volume":"345","author":"Siddique","year":"1995","journal-title":"Zaire Lancet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0160","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0140-6736(91)92789-5","article-title":"Survival of classic cholera in Bangladesh","volume":"337","author":"Siddique","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0165","first-page":"171","article-title":"Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital","volume":"48","author":"Nizami","year":"1998","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.vaccine.2019.06.031_b0170","doi-asserted-by":"crossref","first-page":"e38633","DOI":"10.1371\/journal.pone.0038633","article-title":"Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.031_b0175","doi-asserted-by":"crossref","unstructured":"Kuma GK, Opintan J, Sackey SO, Opintan J. Antibiotic resistance patterns amongst clinical Vibrio cholerae O1 isolates from Accra, Ghana. 2014. Int J Infect Control 2014, v10:i3.","DOI":"10.1016\/j.ijid.2014.03.594"},{"key":"10.1016\/j.vaccine.2019.06.031_b0180","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1462-2920.2007.01502.x","article-title":"Vibrio cholerae non-O1, non-O139 strains isolated before 1992 from Varanasi, India are multiple drug resistant, contain intSXT, dfr18 and aadA5 genes","volume":"10","author":"Mohapatra","year":"2008","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/35020000","article-title":"DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae","volume":"406","author":"Heidelberg","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.06.031_b0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000306","article-title":"Molecular evolution and functional divergence of Vibrio cholerae","volume":"29","author":"Das","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.031_b0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/20715","article-title":"A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria","volume":"399","author":"Karaolis","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.06.031_b0200","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1073\/pnas.0910212107","article-title":"Molecular keys of the tropism of integration of the cholera toxin phage","volume":"107","author":"Das","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.06.031_b0205","doi-asserted-by":"crossref","unstructured":"Das B, Bischerour J and Barre FX. VGJphi integration and excision mechanisms contribute to the genetic diversity of Vibrio cholerae epidemic strains. Proc Natl Acad Sci USA 2011;108:2516\u201321.","DOI":"10.1073\/pnas.1017061108"},{"key":"10.1016\/j.vaccine.2019.06.031_b0210","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fmicb.2014.00650","article-title":"Mechanistic insights into filamentous phage integration in Vibrio cholerae","volume":"5","author":"Das","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.meegid.2014.01.006","article-title":"Dynamics in genome evolution of Vibrio cholerae","volume":"23","author":"Banerjee","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0220","first-page":"225","article-title":"Antimicrobials & cholera: are we stranded?","volume":"133","author":"Ghosh","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.06.031_b0225","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nature09469","article-title":"Satellite phage TLCphi enables toxigenic conversion by CTX phage through dif site alteration","volume":"467","author":"Hassan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.06.031_b0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2012.01.053","article-title":"Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence","volume":"149","author":"Davies","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.06.031_b0235","doi-asserted-by":"crossref","first-page":"16848","DOI":"10.1073\/pnas.1404047111","article-title":"XerD-mediated FtsK-independent integration of TLCvarphi into the Vibrio cholerae genome","volume":"111","author":"Midonet","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.031_b0240","doi-asserted-by":"crossref","first-page":"e47427","DOI":"10.15252\/embr.201847427","article-title":"Filamentous phages: masters of a microbial sharing economy","volume":"20","author":"Hay","year":"2019","journal-title":"EMBO Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.031_b0245","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1128\/AEM.72.4.3054-3057.2006","article-title":"SXT-related integrating conjugative element in New World Vibrio cholerae","volume":"72","author":"Burrus","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0250","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JB.187.5.1740-1750.2005","article-title":"Comparative study of class 1 integron and Vibrio cholerae superintegron integrase activities","volume":"187","author":"Biskri","year":"2005","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.031_b0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/MMBR.00056-13","article-title":"Integrons: past, present, and future","volume":"78","author":"Gillings","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.031_b0260","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00088-17","article-title":"Mobile genetic elements associated with antimicrobial resistance","volume":"31","author":"Partridge","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.06.031_b0265","doi-asserted-by":"crossref","first-page":"e1000786","DOI":"10.1371\/journal.pgen.1000786","article-title":"Comparative ICE genomics: insights into the evolution of the SXT\/R391 family of ICEs","volume":"5","author":"Wozniak","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0270","doi-asserted-by":"crossref","first-page":"e1005298","DOI":"10.1371\/journal.pgen.1005298","article-title":"Replication and active partition of integrative and conjugative elements (ICEs) of the SXT\/R391 family: the line between ICEs and conjugative plasmids is getting thinner","volume":"11","author":"Carraro","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.vaccine.2019.06.031_b0275","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1128\/JB.185.17.5045-5054.2003","article-title":"Control of SXT integration and excision","volume":"185","author":"Burrus","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0280","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/jb.178.14.4157-4165.1996","article-title":"A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139","volume":"178","author":"Waldor","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0285","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-genet-112414-055018","article-title":"Integrative and conjugative elements (ICEs): what they do and how they work","volume":"49","author":"Johnson","year":"2015","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2958.1999.01330.x","article-title":"Site-specific integration of the conjugal Vibrio cholerae SXT element into prfC","volume":"32","author":"Hochhut","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1099\/00221287-72-3-543","article-title":"R factors from Proteus rettgeri","volume":"72","author":"Coetzee","year":"1972","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0300","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1128\/JB.184.15.4259-4269.2002","article-title":"Genomic and functional analyses of SXT, an integrating antibiotic resistance gene transfer element derived from Vibrio cholerae","volume":"184","author":"Beaber","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0305","unstructured":"Armshaw P, Pembroke J. \u201cIntegrative conjugative elements (ICEs) of the SXT\/R391 group as vehicles for acquisition of resistance determinants, stable maintenance and transfer to a wide range of enterobacterial pathogens,\u201d. In: Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education, ed. M\u00e9ndez-Vilas A., editor. (Badajoz: Formatex Research Center), 2013. p. 439\u2013446."},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.031_b0310","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01356-14","article-title":"Acquisition and evolution of SXT-R391 integrative conjugative elements in the seventh-pandemic vibrio cholerae lineage","volume":"5","author":"Spagnoletti","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.06.031_b0315","doi-asserted-by":"crossref","first-page":"e108728","DOI":"10.1371\/journal.pone.0108728","article-title":"Worldwide occurrence of integrative conjugative element encoding multidrug resistance determinants in epidemic Vibrio cholerae O1","volume":"9","author":"Marin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.031_b0320","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2958.1995.tb02368.x","article-title":"Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination","volume":"15","author":"Hall","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0325","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1046\/j.1365-2958.2002.02861.x","article-title":"Bacterial resistance evolution by recruitment of super-integron gene cassettes","volume":"43","author":"Rowe-Magnus","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0330","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrmicro1462","article-title":"Integrons: agents of bacterial evolution","volume":"4","author":"Mazel","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0335","doi-asserted-by":"crossref","first-page":"R764","DOI":"10.1016\/j.cub.2015.07.006","article-title":"Microbial evolution: towards resolving the plasmid paradox","volume":"25","author":"MacLean","year":"2015","journal-title":"Curr Biol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00268990","article-title":"Mobilization of plasmid-borne drug resistance determinants for transfer from Pseudomonas aeruginosa to Escherichia coli","volume":"140","author":"Hedges","year":"1975","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.vaccine.2019.06.031_b0345","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/aem.54.11.2771-2776.1988","article-title":"R plasmids in environmental Vibrio cholerae non-O1 strains","volume":"54","author":"Amaro","year":"1988","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0350","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijmm.2013.02.001","article-title":"Plasmids and the spread of resistance","volume":"303","author":"Carattoli","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0355","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","article-title":"Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study","volume":"11","author":"Walsh","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.031_b0360","first-page":"144","article-title":"The pathogenesis, detection, and prevention of Vibrio parahaemolyticus","volume":"6","author":"Wang","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0365","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1099\/jmm.0.062661-0","article-title":"Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family","volume":"62","author":"Fonseca","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0370","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.46.9.2948-2955.2002","article-title":"Occurrence of antibiotic resistance gene cassettes aac(6')-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India","volume":"46","author":"Thungapathra","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0375","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.06.031_b0380","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.06.031_b0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.031_b0390","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"69","author":"McGrath","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0395","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.06.031_b0400","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/319370","article-title":"Mechanisms of action of antimicrobials: focus on fluoroquinolones","volume":"32","author":"Hooper","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.031_b0405","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0410","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.38.10.2477","article-title":"Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs","volume":"38","author":"Vila","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0415","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3201\/eid1611.100568","article-title":"Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa","volume":"16","author":"Quilici","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.031_b0420","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/AAC.00419-13","article-title":"The comprehensive antibiotic resistance database","volume":"57","author":"McArthur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0425","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(12)60911-8","article-title":"NDM-1 polymicrobial infections including Vibrio cholerae","volume":"380","author":"Darley","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2019.06.031_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162578","article-title":"Mechanism of rifampicin inactivation in Nocardia farcinica","volume":"11","author":"Abdelwahab","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.031_b0435","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/cbic.201000067","article-title":"Antibiotic resistance by enzyme inactivation: from mechanisms to solutions","volume":"11","author":"De Pascale","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.vaccine.2019.06.031_b0440","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/bi201790u","article-title":"Mechanism and diversity of the erythromycin esterase family of enzymes","volume":"51","author":"Morar","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2019.06.031_b0445","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1021\/bi0106787","article-title":"Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis","volume":"40","author":"Mukhtar","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2019.06.031_b0450","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1128\/AAC.01166-12","article-title":"Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes","volume":"56","author":"Spanogiannopoulos","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0455","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.0711939105","article-title":"Rifamycin antibiotic resistance by ADP-ribosylation: structure and diversity of Arr","volume":"105","author":"Baysarowich","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.06.031_b0460","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.vaccine.2019.06.031_b0465","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.44.3.647-650.2000","article-title":"Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli","volume":"44","author":"Kobayashi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2019.06.031_b0470","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/emboj\/19.11.2690","article-title":"The crystal structures of chloramphenicol phosphotransferase reveal a novel inactivation mechanism","volume":"19","author":"Izard","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2019.06.031_b0475","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1369-5274(99)00007-7","article-title":"Aminoglycoside-modifying enzymes","volume":"2","author":"Wright","year":"1999","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0480","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.femsre.2004.04.001","article-title":"Molecular basis of bacterial resistance to chloramphenicol and florfenicol","volume":"28","author":"Schwarz","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.06.031_b0485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1574-6968.1993.tb06344.x","article-title":"Nourseothricin (streptothricin) inactivated by a plasmid pIE636 encoded acetyl transferase of Escherichia coli: location of the acetyl group","volume":"110","author":"Zahringer","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2019.06.031_b0490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/jb.171.1.148-153.1989","article-title":"Novel aerobic tetracycline resistance gene that chemically modifies tetracycline","volume":"171","author":"Speer","year":"1989","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ja.2009.116","article-title":"Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance","volume":"63","author":"Hoshino","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.vaccine.2019.06.031_b0500","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1128\/AEM.00873-08","article-title":"Metagenomic screening for bleomycin resistance genes","volume":"74","author":"Mori","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0505","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1128\/JB.01902-06","article-title":"The SXT\/R391 family of integrative conjugative elements is composed of two exclusion groups","volume":"189","author":"Marrero","year":"2007","journal-title":"J Bacteriol"},{"issue":"7365","key":"10.1016\/j.vaccine.2019.06.031_b0510","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature10392","article-title":"Evidence for multiple waves of global transmission within the seventh cholera pandemic","volume":"477","author":"Mutreja","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.06.031_b0515","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1128\/JCM.40.9.3296-3299.2002","article-title":"New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh","volume":"40","author":"Nair","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0520","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00203-007-0275-0","article-title":"Small chromosomal integration site of classical CTX prophage in Mozambique Vibrio cholerae O1 biotype El Tor strain","volume":"188","author":"Das","year":"2007","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0525","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1128\/AEM.72.4.3054-3057.2006","article-title":"SXT-related integrating conjugative element in New World Vibrio cholerae","volume":"72","author":"Burrus","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0530","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.031_b0535","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:41Z","timestamp":1759401581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":107,"alternative-id":["S0264410X19307935"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}